vs
FIVE BELOW, INC（FIVE）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是FIVE BELOW, INC的1.4倍（$1.4B vs $1.0B），瑞思迈净利率更高（27.6% vs 3.5%，领先24.1%），FIVE BELOW, INC同比增速更快（23.1% vs 11.0%），瑞思迈自由现金流更多（$311.2M vs $-133.2M），过去两年瑞思迈的营收复合增速更高（9.0% vs -11.9%）
Five Below是美国特色折扣礼品连锁品牌，2002年成立，总部位于宾夕法尼亚州费城，主要面向青少年消费群体，旗下绝大多数商品定价不超过5美元，另有少量精选商品最高定价40美元，目前在全美拥有超过1850家线下门店。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
FIVE vs RMD — 直观对比
营收规模更大
RMD
是对方的1.4倍
$1.0B
营收增速更快
FIVE
高出12.1%
11.0%
净利率更高
RMD
高出24.1%
3.5%
自由现金流更多
RMD
多$444.4M
$-133.2M
两年增速更快
RMD
近两年复合增速
-11.9%
损益表 — Q3 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $1.4B |
| 净利润 | $36.5M | $392.6M |
| 毛利率 | 33.8% | 61.8% |
| 营业利润率 | 4.2% | 34.6% |
| 净利率 | 3.5% | 27.6% |
| 营收同比 | 23.1% | 11.0% |
| 净利润同比 | 2063.9% | 13.9% |
| 每股收益（稀释后） | $0.66 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FIVERMD
| Q4 25 | $1.0B | $1.4B | ||
| Q3 25 | $1.0B | $1.3B | ||
| Q2 25 | $970.5M | $1.3B | ||
| Q1 25 | $1.4B | $1.3B | ||
| Q4 24 | $843.7M | $1.3B | ||
| Q3 24 | $830.1M | $1.2B | ||
| Q2 24 | $811.9M | $1.2B | ||
| Q1 24 | $1.3B | $1.2B |
净利润FIVERMD
| Q4 25 | $36.5M | $392.6M | ||
| Q3 25 | $42.8M | $348.5M | ||
| Q2 25 | $41.1M | $379.7M | ||
| Q1 25 | $187.5M | $365.0M | ||
| Q4 24 | $1.7M | $344.6M | ||
| Q3 24 | $33.0M | $311.4M | ||
| Q2 24 | $31.5M | $292.2M | ||
| Q1 24 | $202.2M | $300.5M |
毛利率FIVERMD
| Q4 25 | 33.8% | 61.8% | ||
| Q3 25 | 33.3% | 61.5% | ||
| Q2 25 | 33.4% | 60.8% | ||
| Q1 25 | 40.2% | 59.3% | ||
| Q4 24 | 30.6% | 58.6% | ||
| Q3 24 | 32.7% | 58.6% | ||
| Q2 24 | 32.5% | 58.5% | ||
| Q1 24 | 41.2% | 57.9% |
营业利润率FIVERMD
| Q4 25 | 4.2% | 34.6% | ||
| Q3 25 | 5.1% | 33.4% | ||
| Q2 25 | 5.2% | 33.7% | ||
| Q1 25 | 17.7% | 33.0% | ||
| Q4 24 | -0.1% | 32.5% | ||
| Q3 24 | 5.0% | 31.6% | ||
| Q2 24 | 4.5% | 31.2% | ||
| Q1 24 | 20.1% | 31.3% |
净利率FIVERMD
| Q4 25 | 3.5% | 27.6% | ||
| Q3 25 | 4.2% | 26.1% | ||
| Q2 25 | 4.2% | 28.2% | ||
| Q1 25 | 13.5% | 28.3% | ||
| Q4 24 | 0.2% | 26.9% | ||
| Q3 24 | 4.0% | 25.4% | ||
| Q2 24 | 3.9% | 23.9% | ||
| Q1 24 | 15.1% | 25.1% |
每股收益（稀释后）FIVERMD
| Q4 25 | $0.66 | $2.68 | ||
| Q3 25 | $0.77 | $2.37 | ||
| Q2 25 | $0.75 | $2.58 | ||
| Q1 25 | $3.40 | $2.48 | ||
| Q4 24 | $0.03 | $2.34 | ||
| Q3 24 | $0.60 | $2.11 | ||
| Q2 24 | $0.57 | $1.97 | ||
| Q1 24 | $3.64 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $524.5M | $1.4B |
| 总债务越低越好 | — | $403.9M |
| 股东权益账面价值 | $2.0B | $6.3B |
| 总资产 | $4.8B | $8.5B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资FIVERMD
| Q4 25 | $524.5M | $1.4B | ||
| Q3 25 | $670.2M | $1.4B | ||
| Q2 25 | $624.0M | $1.2B | ||
| Q1 25 | $528.8M | $932.7M | ||
| Q4 24 | $216.6M | $521.9M | ||
| Q3 24 | $327.7M | $426.4M | ||
| Q2 24 | $369.6M | $238.4M | ||
| Q1 24 | $460.1M | $237.9M |
总债务FIVERMD
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M | ||
| Q2 24 | — | $697.3M | ||
| Q1 24 | — | $997.0M |
股东权益FIVERMD
| Q4 25 | $2.0B | $6.3B | ||
| Q3 25 | $1.9B | $6.1B | ||
| Q2 25 | $1.9B | $6.0B | ||
| Q1 25 | $1.8B | $5.5B | ||
| Q4 24 | $1.6B | $5.3B | ||
| Q3 24 | $1.6B | $5.2B | ||
| Q2 24 | $1.6B | $4.9B | ||
| Q1 24 | $1.6B | $4.6B |
总资产FIVERMD
| Q4 25 | $4.8B | $8.5B | ||
| Q3 25 | $4.6B | $8.3B | ||
| Q2 25 | $4.5B | $8.2B | ||
| Q1 25 | $4.3B | $7.6B | ||
| Q4 24 | $4.2B | $7.1B | ||
| Q3 24 | $4.0B | $7.2B | ||
| Q2 24 | $3.9B | $6.9B | ||
| Q1 24 | $3.9B | $6.8B |
负债/权益比FIVERMD
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-80.1M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $-133.2M | $311.2M |
| 自由现金流率自由现金流/营收 | -12.8% | 21.9% |
| 资本支出强度资本支出/营收 | 5.1% | 2.0% |
| 现金转化率经营现金流/净利润 | -2.19× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $323.0M | $1.8B |
8季度趋势，按日历期对齐
经营现金流FIVERMD
| Q4 25 | $-80.1M | $339.7M | ||
| Q3 25 | $93.0M | $457.3M | ||
| Q2 25 | $132.7M | $538.8M | ||
| Q1 25 | $363.5M | $578.7M | ||
| Q4 24 | $-30.6M | $308.6M | ||
| Q3 24 | $71.3M | $325.5M | ||
| Q2 24 | $26.4M | $440.1M | ||
| Q1 24 | $407.7M | $402.0M |
自由现金流FIVERMD
| Q4 25 | $-133.2M | $311.2M | ||
| Q3 25 | $48.3M | $414.4M | ||
| Q2 25 | $96.5M | $508.2M | ||
| Q1 25 | $311.4M | $557.9M | ||
| Q4 24 | $-111.0M | $288.0M | ||
| Q3 24 | $-32.4M | $307.7M | ||
| Q2 24 | $-61.4M | $415.2M | ||
| Q1 24 | $304.6M | $380.8M |
自由现金流率FIVERMD
| Q4 25 | -12.8% | 21.9% | ||
| Q3 25 | 4.7% | 31.0% | ||
| Q2 25 | 9.9% | 37.7% | ||
| Q1 25 | 22.4% | 43.2% | ||
| Q4 24 | -13.2% | 22.5% | ||
| Q3 24 | -3.9% | 25.1% | ||
| Q2 24 | -7.6% | 33.9% | ||
| Q1 24 | 22.8% | 31.8% |
资本支出强度FIVERMD
| Q4 25 | 5.1% | 2.0% | ||
| Q3 25 | 4.4% | 3.2% | ||
| Q2 25 | 3.7% | 2.3% | ||
| Q1 25 | 3.7% | 1.6% | ||
| Q4 24 | 9.5% | 1.6% | ||
| Q3 24 | 12.5% | 1.5% | ||
| Q2 24 | 10.8% | 2.0% | ||
| Q1 24 | 7.7% | 1.8% |
现金转化率FIVERMD
| Q4 25 | -2.19× | 0.87× | ||
| Q3 25 | 2.17× | 1.31× | ||
| Q2 25 | 3.22× | 1.42× | ||
| Q1 25 | 1.94× | 1.59× | ||
| Q4 24 | -18.13× | 0.90× | ||
| Q3 24 | 2.16× | 1.05× | ||
| Q2 24 | 0.84× | 1.51× | ||
| Q1 24 | 2.02× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FIVE
暂无分部数据
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
